glp-1 obesity drug news october 9 2025 Poll: 1 in 8 Adults Say They Are Currently Taking a for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford Weighty issue: GLP-1 drugs are

Fat, fibre and cancer risk in African Americans and rural Africans

This low-dose approach turns the drug into a manageable background aid rather than a dominant physiological force

Role of the hexosamine biosynthetic pathway in diabetic nephropathy

Toll-like receptors (TLRs) play a key role in microorganism and viral particle recognition and activation of the innate immune system (Sasai and Yamamoto, 2013

The 6-month oral glutathione RCT documented more than a twofold increase in natural killer (NK) cell cytotoxicity in the high-dose group, and liposomal glutathione raised NK cell cytotoxicity by up to 400% and lymphocyte proliferation by up to 60% in a pilot trial

Eli Lilly has adopted a pricing strategy that undercuts Novo Nordisk, offering Zepbound at a lower price for uninsured patients, with some paying as little as $399 per month